| 000 | 01981cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030832.0 | ||
| 008 | 130519s2013 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.11.18.Ph.D.2013.Am.R | ||
| 100 | 0 | _aAmr Mohamed Shaker Hafez | |
| 245 | 1 | 0 |
_aRelation of serum retinol - binding protein and vaspin to metabolic syndrome in chronic kidney disease / _cAmr Mohamed Shaker Hafez ; Supervised Omar Yehia Elkhashab , Mohammed Mostafa Elkhateeb , Amal Rashad Elshehaby |
| 246 | 1 | 5 | _aالعلاقة بين بروتين الريتينول الملازم 4 والفاسبن مع المتلازمة الأيضية فى مرضى القصور الكلوى المزمن |
| 260 |
_aCairo : _bAmr Mohamed Shaker Hafez , _c2013 |
||
| 300 |
_a119P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Internal Medicine | ||
| 520 | _aCKD and ESRD is associated with an adverse cardiovascular prognosis that led both the national kidney foundation and the American college of cardiology American heart association to recommend that CKD be considered a CHD risk equivalent . A secondary analysis from the ARIC study confirmed the increase in cardiovascular risk associated with CKD dyslipidemia hypertension and atherogenesis are co'morbid conditions in addition to insulin resistance that are associated with obesity and adversely influenced by the sceretion of these adipokines | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aProtein | |
| 653 | 4 | _aSerum retinol - binding | |
| 653 | 4 | _aVaspin | |
| 700 | 0 |
_aAmal Rashad Elshehaby , _eSupervisor |
|
| 700 | 0 |
_aMohammed Mostafa Elkhateeb , _eSupervisor |
|
| 700 | 0 |
_aOmar Yehia Elkhashab , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c42942 _d42942 |
||